Ono Pharmaceutical Co. Ltd. logo

Ono Pharmaceutical Co. Ltd.

OPHLY | OTC
Chart Builder DCF Calculator
$5.30
+$0.15 (+2.91%)
Sep 22, 2026, 11:42 AM ET · Market open
Fiscal Year
Period Ending
FY 2026
Mar 30, 2026
FY 2025
Mar 30, 2025
FY 2024
Mar 30, 2024
FY 2023
Mar 30, 2023
FY 2022
Mar 30, 2022
FY 2021
Mar 30, 2021
Net Income
73.97B 59.33B 127.98B 143.53B 105.03B 100.89B
Depreciation & Amortization
40.03B 26.89B 18.14B 17.45B 17.72B 15.82B
Stock-Based Compensation
n/a n/a n/a n/a n/a n/a
Other Working Capital
28.93B 18.51B -3.92B 5.81B -20.54B 410M
Other Non-Cash Items
8.25B -42.1B -6.5B -2.81B -30.81B -36.22B
Deferred Income Tax
n/a n/a n/a n/a n/a n/a
Change in Working Capital
22.82B 38.34B -28.96B 1.44B -30.11B -6.52B
Operating Cash Flow
145.07B 82.46B 110.66B 159.61B 61.83B 73.98B
Capital Expenditures
-6.39B -7.99B -20.83B -14.5B -12.28B -20.29B
Cash Acquisitions
22.27M -364.82B 6.25M -9.15B -6.77B -13.27B
Purchase of Investments
-4.71B -4.08B -36.73B -140.59B -58.61B -81.7B
Sales Maturities Of Investments
19.8B 240.84B 106.02B 55.86B 78.58B 44.83B
Other Investing Acitivies
-894.9M -3.3B -17.19B 8.12B 5.11B 12.85B
Investing Cash Flow
-42.26B -136.79B 48.08B -100.26B 6.04B -57.59B
Debt Repayment
-26.1B 135B n/a n/a n/a n/a
Common Stock Repurchased
-1.06M -1M -50.01B -1M -30.01B -3M
Dividend Paid
-39.8B -37.52B -37.18B -29.74B -27.67B -22.45B
Other Financial Acitivies
-3.55B -3.18B -2.66B -2.74B -2.56B -2.3B
Financial Cash Flow
-69.44B 94.3B -89.85B -32.48B -60.24B -24.75B
Net Cash Flow
19.5B 38.43B 70.01B 27.02B 8.07B -7.96B
Free Cash Flow
138.69B 74.47B 89.83B 145.11B 49.55B 53.68B
Adj. Free Cash Flow
138.69B 74.47B 89.83B 145.11B 49.55B 53.68B
Maintenance CapEx
n/a -7.99B -3.78B n/a n/a -13.66B
Growth CapEx
-6.39B n/a -17.05B -14.5B -12.28B -6.64B
Owner Earnings
145.07B 74.47B 106.88B 159.61B 61.83B 60.32B

© 2026 bestshares.com. All rights reserved.